These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9214412)

  • 1. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myelocytic leukemia.
    Honda K; Ando A; Endo M; Shimizu K; Higashihara M; Nitta K; Nihei H
    Am J Kidney Dis; 1997 Jul; 30(1):123-30. PubMed ID: 9214412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
    Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
    Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal of interferon-alpha results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-alpha.
    Ohashi N; Yonemura K; Sugiura T; Isozaki T; Togawa A; Fujigaki Y; Yamamoto T; Hishida A
    Am J Kidney Dis; 2003 Mar; 41(3):E10. PubMed ID: 12613003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal thrombotic microangiopathy associated with interferon-alpha treatment of chronic myeloid leukemia.
    Magee CC; Abraham K; Farrell J; Dorman T; Walshe JJ
    Am J Kidney Dis; 2000 Jul; 36(1):E5. PubMed ID: 10873904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal thrombotic microangiopathy induced by interferon-alpha.
    Badid C; McGregor B; Faivre JM; Guerard A; Juillard L; Fouque D; Laville M
    Nephrol Dial Transplant; 2001 Apr; 16(4):846-8. PubMed ID: 11274286
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effect?
    Ravandi-Kashani F; Cortes J; Talpaz M; Kantarjian HM
    Cancer; 1999 Jun; 85(12):2583-8. PubMed ID: 10375106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic microangiopathy in a patient with chronic myelogenous leukemia on hydroxyurea.
    Shammas F; Meyer P; Heikkila R; Apeland T; Gøransson L; Berland J; Kjellevold K
    Acta Haematol; 1997; 97(3):184-6. PubMed ID: 9066715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic microangiopathy in a patient with chronic myelocytic leukaemia treated with alpha-interferon.
    Vacher-Coponat H; Opris A; Daniel L; Harle JR; Veit V; Olmer M
    Nephrol Dial Transplant; 1999 Oct; 14(10):2469-71. PubMed ID: 10528675
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemolytic uremic syndrome-like episode following nonmyeloablative hematopoietic stem cell transplantation in a patient with chronic myeloid leukemia].
    Takahashi N; Miura I; Kume M; Kawabata Y; Hirokawa M; Sawada K
    Rinsho Ketsueki; 2003 Jun; 44(6):391-5. PubMed ID: 12884818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic-uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alpha.
    Schlaifer D; Dumazer P; Spenatto N; Mignon-Conte M; Brousset P; Lumbroso C; Cooper M; Muller C; Huguet F; Attal M
    Am J Hematol; 1994 Nov; 47(3):254-5. PubMed ID: 7942805
    [No Abstract]   [Full Text] [Related]  

  • 11. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa].
    Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E
    Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
    Bremer CT; Lastrapes A; Alper AB; Mudad R
    Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with interferon-alpha. A report of two successfully treated patients.
    Rachmani R; Avigdor A; Youkla M; Raanani P; Zilber M; Ravid M; Ben-Bassat I
    Acta Haematol; 1998; 100(4):204-6. PubMed ID: 9973644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal thrombotic microangiopathy induced by interferon-alpha.
    Magee CC
    Nephrol Dial Transplant; 2001 Oct; 16(10):2111-2. PubMed ID: 11572913
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interferon-alpha 2b.
    Jadoul M; Piessevaux H; Ferrant A; Cosyns JP; van Ypersele de Strihou C
    Nephrol Dial Transplant; 1995; 10(1):111-3. PubMed ID: 7724004
    [No Abstract]   [Full Text] [Related]  

  • 16. [Case of chronic myelogenous leukemia with hemolytic-uremic-syndrome like kidney during long-term interferon-alpha therapy].
    Kobayashi H; Utsunomiya Y; Miyazaki Y; Tokutome G; Kawamura T; Hashimoto T; Sakai T; Takahashi S; Tojyo A; Asano S
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1259-61. PubMed ID: 9379108
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of hyperthyroidism during long term interferon therapy in a patient with chronic myelogenous leukemia: case report.
    Ozet A; Ozet G; Calişkaner Z; Kömürcü S; Oztürk B
    Endocr J; 1997 Oct; 44(5):715-7. PubMed ID: 9466328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alpha sensitisation induced fatal renal insufficiency in a patient with chronic myeloid leukaemia: case report and review of literature.
    Colovic M; Jurisic V; Jankovic G; Jovanovic D; Nikolic LJ; Dimitrijevic J
    J Clin Pathol; 2006 Aug; 59(8):879-81. PubMed ID: 16873566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia.
    Budak-Alpdoğan T; Lawrence RA; Bayik M; Akoğlu E
    Clin Nephrol; 1997 Jul; 48(1):59-60. PubMed ID: 9247783
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombotic thrombocytopenic purpura during interferon alpha treatment for chronic myelogenous leukemia.
    Lacotte L; Thierry A; Delwail V; Dreyfus B; Guilhot F
    Acta Haematol; 2000; 102(3):160-2. PubMed ID: 10692682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.